Starting a weight loss treatment is one thing. Knowing what to actually expect along the way is another.
If you’ve been looking into semaglutide or tirzepatide injections, you’ve probably already done some research. You’ve seen results. You’ve heard the conversations. And somewhere in the back of your mind, you’re asking the same question everyone asks: how long until I see real progress?
Here’s what the research shows, and what you can expect as you move through treatment.
How These Medications Work
Before getting into timelines, it helps to understand what semaglutide and tirzepatide are doing inside your body.
Both are GLP-1 receptor agonists, meaning they mimic GLP-1, a hormone your body naturally produces to regulate appetite and blood sugar. According to clinical research published in PMC, semaglutide reduces appetite, stimulates satiety, and decreases overall energy intake. A double-blind clinical study published in Diabetes, Obesity and Metabolism found that meal tests showed a reduction in appetite and energy intake with semaglutide, along with better control of eating and fewer, weaker food cravings.
Tirzepatide takes things a step further. It is a dual GIP and GLP-1 receptor agonist, activating two hormone pathways instead of one. That’s a meaningful part of why tirzepatide tends to produce stronger results for many patients.
Neither medication is a quick fix. They work with your biology over time, which is exactly why the timeline matters.
The Weight Loss Timeline: What the Research Shows
Weeks 1 to 4
The first month is largely about letting your body acclimate. According to PMC clinical guidance, semaglutide doses usually start at 0.25 mg once weekly, with dose increasing every four weeks until the full dose of 2.4 mg is reached, in order to minimize gastrointestinal side effects.
Months 2 to 3
As doses increase and the medication reaches therapeutic levels, weight loss becomes more consistent and noticeable.
The STEP 1 trial data published in the New England Journal of Medicine shows that meaningful weight-loss progress typically builds through the early months, with the largest cumulative changes occurring between months 3 and 12.
Months 3 to 12
This window is where the most significant changes happen. The STEP 1 trial found that among overweight or obese adults without diabetes, once-weekly semaglutide plus lifestyle intervention produced a mean weight loss of 14.9%, with 86% of participants attaining at least 5% weight loss over 68 weeks.
The SURMOUNT-1 trial showed even stronger outcomes for tirzepatide: participants achieved average weight reductions of 16.0% at 5 mg, 21.4% at 10 mg, and 22.5% at 15 mg compared to placebo over 72 weeks.
Real-world data from a 12-month remote weight management program found mean weight loss of roughly 22% at 12 months in the tirzepatide group and 17% in the semaglutide group, with at least 10% weight loss achieved by 95% of tirzepatide participants and 83% of semaglutide participants.
Semaglutide vs. Tirzepatide: What the Head-to-Head Data Shows
For years, clinicians compared these two medications across separate trials with different patient populations. That changed in 2025.
In the Phase 3b SURMOUNT-5 trial, tirzepatide demonstrated significantly greater weight loss compared with semaglutide in adults with obesity without diabetes. Over 72 weeks, participants on tirzepatide achieved a mean body weight reduction of 20.2% compared to 13.7% for those on semaglutide. Tirzepatide users were also more likely to achieve reductions of at least 10 to 25% in body weight and showed greater reductions in waist circumference.
Both medications produce significant results. Tirzepatide produces greater overall weight loss for many patients, but the right choice depends on your starting point, medical history and your healthcare provider’s recommendations.
What You Can Do to Support Your Results
These medications regulate appetite and metabolic signaling. What you do alongside it determines how long the results last.
Focus on Protein and Fiber
High-protein, fiber-rich meals work well with these medications because they extend satiety and require more energy to digest. Lean proteins, vegetables, whole grains, and legumes help preserve muscle while losing fat.
Stay Active
A 12-month remote weight management study found that the proportion of inactive participants dropped substantially in both the semaglutide and tirzepatide groups over the course of treatment, underscoring how movement supports outcomes. Aim for at least 150 minutes of moderate-intensity exercise per week, with strength training mixed in. The type of movement matters less than the consistency of it.
Stay Consistent With the Process
Patients who see the strongest outcomes tend to be those who stay engaged, keep their check-ins, and treat the process as a long-term commitment rather than a short-term experiment. Appetite changes early. Body composition changes take time. Both are part of the same process.
Ready to Get Started?
At Rehydra + Wellness, accessing semaglutide or tirzepatide weight loss treatment is straightforward. Our telehealth model means no waiting rooms, no complicated processes, and medication shipped directly to your door. You get responsive support, clear communication, and a simple cash-pay process.
We’re LegitScript certified and here when you have questions.
Get started today and find out if semaglutide or tirzepatide is right for you.
